Safe and Efficient: Containment Solutions for Highly Potent Active Ingredients
Highly potent APIs: opportunities and challenges
Highly potent pharmaceutical ingredients (HPAPIs) offer tremendous therapeutic benefits—especially in oncology and for rare diseases. Their effectiveness at minimal dosages, however, brings significant occupational safety requirements. HPAPIs classified as OEB5 require exposure limits below 1 µg/m³, necessitating highly advanced containment systems.
ZETA addresses these challenges with customized, GMP-compliant solutions that ensure both employee safety and product integrity.
Engineering expertise for the future of drug manufacturing
ZETA supports pharmaceutical manufacturers from early development through to commercial production. Its modular and scalable plant solutions enable maximum flexibility—whether for research units or large-scale facilities.
A best-practice example is the design and implementation of a downstream system for antibody-drug conjugates (ADCs), completed in just 18 months.
With isolator-protected environments, independent operating units, and well-integrated processes, ZETA sets new standards in the safe production of highly potent pharmaceuticals.
Download the Technical Article
High-Potency APIs and Containment Engineering
